These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26593695)

  • 41. Crohn's disease outcome in patients under azathioprine: a tertiary referral center experience.
    Magro F; Santos-Antunes J; Vilas-Boas F; Rodrigues-Pinto E; Coelho R; Ribeiro OS; Lopes S; Macedo G
    J Crohns Colitis; 2014 Jul; 8(7):617-25. PubMed ID: 24332869
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Salivary changes in oxidative stress related to inflammation in oral and gastrointestinal diseases.
    Janšáková K; Escudier M; Tóthová Ľ; Proctor G
    Oral Dis; 2021 Mar; 27(2):280-289. PubMed ID: 32643850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Orofacial granulomatosis: clinical features and long-term outcome of therapy.
    Al Johani KA; Moles DR; Hodgson TA; Porter SR; Fedele S
    J Am Acad Dermatol; 2010 Apr; 62(4):611-20. PubMed ID: 20137827
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Azathioprine as a postoperative prophylaxis reduces symptoms in aggressive Crohn's disease.
    Myrelid P; Svärm S; Andersson P; Almer S; Bodemar G; Olaison G
    Scand J Gastroenterol; 2006 Oct; 41(10):1190-5. PubMed ID: 16990204
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Orofacial granulomatosis and erythema multiforme in an adolescent with Crohn's disease.
    Georgesen C; Huang J; Avarbock A; Harp J; Magro C
    Pediatr Dermatol; 2018 Sep; 35(5):e294-e297. PubMed ID: 30024055
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
    Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
    Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of orofacial granulomatosis: a case report.
    Badshah MB; Walayat S; Ahmed U; Dhillon S; Yong S; Kane S; Thievanayagam S
    J Med Case Rep; 2017 Oct; 11(1):300. PubMed ID: 29065902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Orofacial granulomatosis as the initial presentation of Crohn's disease in an adolescent.
    Bogenrieder T; Rogler G; Vogt T; Landthaler M; Stolz W
    Dermatology; 2003; 206(3):273-8. PubMed ID: 12673090
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Childhood and adolescent orofacial granulomatosis is strongly associated with Crohn's disease and responds to intralesional corticosteroids.
    Tuxen AJ; Orchard D
    Australas J Dermatol; 2010 May; 51(2):124-7. PubMed ID: 20546219
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical evidence for allergy in orofacial granulomatosis and inflammatory bowel disease.
    Patel P; Brostoff J; Campbell H; Goel RM; Taylor K; Ray S; Lomer M; Escudier M; Challacombe S; Spencer J; Sanderson J
    Clin Transl Allergy; 2013 Aug; 3(1):26. PubMed ID: 23947721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uncommon inflammatory swelling of the lips: orofacial granulomatosis.
    Hafiz A; Mufeed A; Kandasamy G; Krishnapillai R
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26759437
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Early azathioprine/biological therapy is associated with decreased risk for first surgery and delays time to surgery but not reoperation in both smokers and nonsmokers with Crohn's disease, while smoking decreases the risk of colectomy in ulcerative colitis.
    Szamosi T; Banai J; Lakatos L; Czegledi Z; David G; Zsigmond F; Pandur T; Erdelyi Z; Gemela O; Papp M; Papp J; Lakatos PL
    Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):872-9. PubMed ID: 19648821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Efficacy of azathioprine in mild or moderate relapse in Crohn's disease: clinical and endoscopic evaluation.
    Murakami Y; Matsui T; Hirai F; Takatsu N; Takaki Y; Nagahama T; Hisabe T; Beppu T; Miyaoka M; Maki S; Takeichi M; Nishimura T; Ueki T; Yao K
    Dig Endosc; 2010 Jan; 22(1):25-32. PubMed ID: 20078661
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Therapy of metronidazole with azathioprine to prevent postoperative recurrence of Crohn's disease: a controlled randomized trial.
    D'Haens GR; Vermeire S; Van Assche G; Noman M; Aerden I; Van Olmen G; Rutgeerts P
    Gastroenterology; 2008 Oct; 135(4):1123-9. PubMed ID: 18727929
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Azathioprine is more effective than mesalazine at preventing recurrent bowel obstruction in patients with ileocecal Crohn's disease.
    Vidigal FM; de Souza GS; Chebli LA; da Rocha Ribeiro TC; Furtado MC; Castro AC; Pinto AL; do Valle Pinheiro B; de Lima Pace FH; Machado de Oliveira J; de Oliveira Zanini KA; Gaburri PD; Zanini A; Ribeiro LC; Chebli JM
    Med Sci Monit; 2014 Nov; 20():2165-70. PubMed ID: 25370731
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Validation of endoscopic activity scores in patients with Crohn's disease based on a post hoc analysis of data from SONIC.
    Ferrante M; Colombel JF; Sandborn WJ; Reinisch W; Mantzaris GJ; Kornbluth A; Rachmilewitz D; Lichtiger S; D'Haens GR; van der Woude CJ; Danese S; Diamond RH; Oortwijn AF; Tang KL; Miller M; Cornillie F; Rutgeerts PJ;
    Gastroenterology; 2013 Nov; 145(5):978-986.e5. PubMed ID: 23954314
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biologics in oral medicine: oral Crohn's disease and orofacial granulomatosis.
    O'Neill ID; Scully C
    Oral Dis; 2012 Oct; 18(7):633-8. PubMed ID: 22420719
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Azathioprine treatment in inflammatory bowel disease patients: type and time of onset of side effects.
    Avallone EV; Pica R; Cassieri C; Zippi M; Paoluzi P; Vernia P
    Eur Rev Med Pharmacol Sci; 2014; 18(2):165-70. PubMed ID: 24488903
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A case of therapy-related myeloid neoplasm in a patient with Crohn's disease treated with azathioprine.
    Mullier F; Rahier JF; Maignen F; Cornet Y; Graux C; Chatelain C; Chatelain B; Dogne JM
    Acta Haematol; 2012; 128(1):1-6. PubMed ID: 22572218
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative effectiveness of azathioprine in Crohn's disease and ulcerative colitis: prospective, long-term, follow-up study of 394 patients.
    Gisbert JP; Niño P; Cara C; Rodrigo L
    Aliment Pharmacol Ther; 2008 Jul; 28(2):228-38. PubMed ID: 18485129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.